Reconstitution
2 mg vial
APE2

Adipotide 2 mg

Educational recon guide for a 2 mg Adipotide (FTPP) research vial and daily SC unit mapping. Research use only — renal risk discussions apply.

Vial size

Same research phases — calculator defaults and unit math match the selected vial strength.

Vial

2 mg

Your BAC water

1 mL

Concentration

2.00 mg/mL

Per unit

~20.0 mcg

Frequency

Once daily subcutaneous (often framed as ~28-day courses)

Route

Subcutaneous

Live reconstitution calculator

Defaults match this guide (2 mg + 1 mL BAC). Change water or dose and the unit tables below update automatically.

Step 1

Reconstitution

Peptide amount in the vial and how much bacteriostatic water you add.

Bacteriostatic water (mL)
Concentration2 mg/mL
Per 1 unit (0.01 mL)20 mcg
Per 10 units (0.1 mL)200 mcg

Step 2

Your dose

This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).

Desired dose

Quick select (mcg) — switch units or type any value

Insulin syringe (U-100)

Suggested: 30-unit barrel (smallest that fits this draw).

Your draw

Results

Total draw

25 units

Volume

0.250 mL

Doses per vial

4

Syringes needed

1

Barrel

30-unit

Fits one syringe?

Yes

30-unit · 0.3 mL

Filled to 25 u

Fill one 30-unit U-100 syringe to about 25 units (0.250 mL).

Research cycle phases

Units and volumes recompute from your Step 1 concentration (1 mL BAC → 2.00 mg/mL · 20.0 mcg/unit). Doses below are once daily during the course — not weekly.

Standard course

Nonhuman primate work explored ~0.25–0.75 mg/kg SC daily for ~28 days. Fixed educational tables often discuss ~0.5–2 mg/day absolute — strong renal cautions apply.

Live from Step 1
PhaseDaily doseUnitsVolume
Days 1–7 (conservative)500 mcg0.5 mg25 u0.25 mL
Days 8–28 (standard educational)1 mg1,000 mcg50 u0.50 mL1 mg daily — not a safety endorsement

Alternate / higher courses

Shorter or higher daily courses discussed in research communities — not a clinical recommendation

Live from Step 1
PhaseDaily doseUnitsVolume
Higher educational · 2 mg daily × 282 mg2,000 mcg100 u1.00 mLRenal monitoring narratives apply

Supplies planner

Using the guide’s phase ladder (500 mcg → 1 mg per injection (phase ladder)) over a 28-day course. Set a dose in Step 2 to plan supplies at your own amount.

Updates with calculator

Your recon

1 mL · 2.00 mg/mL

Dose in plan

Phase ladder

Syringe size

100-unit

Horizon

28-day course

Adipotide 2 mg vials

13 vials

~24.5 mg mg total peptide over this 28-day course at 500 mcg → 1 mg per injection (phase ladder). Each vial holds 2 mg.

Bacteriostatic water

5 × 3 mL or 2 × 10 mL

1 mL BAC per vial × 13 vials = 13.0 mL total. Buy as 5× 3 mL bottles or 2× 10 mL bottles (whichever you stock).

U-100 insulin syringes (100-unit)

28+ syringes

About one 100-unit syringe per injection for this schedule. Keep a few spares.

Alcohol swabs & sharps

~82 swabs · 1 sharps container

Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.

Reconstitution steps

  1. Allow the lyophilized 2 mg Adipotide vial and bacteriostatic water to reach room temperature.
  2. Draw 1.0 mL bacteriostatic water (default for this guide).
  3. Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
  4. Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
  5. Label with recon date and concentration (e.g. "2.0 mg/mL — 1 mL BAC").
  6. Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.

Storage

Lyophilized

Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).

Reconstituted

Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.

  • ·Write recon date and BAC volume on the label.
  • ·Protect from light during storage.
  • ·Discard if cloudy, particulates, or odd odor appear after reconstitution.

Protocol notes

  • ·Adipotide (FTPP) is experimental.
  • ·Animal data linked higher doses to creatinine changes.
  • ·Research use only. Not medical advice.

Research context & considerations

Adipotide was designed to target white adipose vasculature. Not an approved weight-loss medicine.

  • ·Renal laboratory abnormalities in animals are a central safety discussion.
  • ·Not FDA-approved for fat loss.
  • ·Anyone with kidney disease should not experiment with research adipotide.
  • ·Pregnancy and pediatric use out of scope.

Catalog match

Adipotide/FTTP (APE2)

2mg x 10 vials · from $35

Add to quote